Pages that link to "Q38050099"
Jump to navigation
Jump to search
The following pages link to Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders (Q38050099):
Displaying 11 items.
- Genetic alterations affecting cholesterol metabolism and human fertility (Q35617057) (← links)
- Delivery of the 7-dehydrocholesterol reductase gene to the central nervous system using adeno-associated virus vector in a mouse model of Smith-Lemli-Opitz Syndrome (Q36024854) (← links)
- Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine (Q38718368) (← links)
- Oxidative stress, serotonergic changes and decreased ultrasonic vocalizations in a mouse model of Smith-Lemli-Opitz syndrome (Q38755055) (← links)
- Antioxidants: The Missing Key to Improved Therapeutic Intervention in Smith-Lemli-Opitz Syndrome? (Q41849702) (← links)
- Novel DHCR7 mutation in a case of Smith-Lemli-Opitz syndrome showing 46,XY disorder of sex development. (Q42278762) (← links)
- Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome (Q49209763) (← links)
- Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease. (Q54566097) (← links)
- Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients. (Q54858134) (← links)
- Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome (Q63285906) (← links)
- Statins for Smith-Lemli-Opitz syndrome (Q90054585) (← links)